Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.7 |
mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.7 |